China Money Network
Login
Join

CMB Leads $65M Series C Round In Chinese Biotech Firm Biocytogen

  • April 10, 2018 — 10:29 CST

This Data Is Locked!

This area is available only to Subscribers.

CMB International Capital Corporation Ltd, a wholly-owned subsidiary of China Merchants Bank, has led a RMB410 million (US$65 million) series C round in Beijing Biocytogen... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: